Introduction. Anti-secretory factor is a protein that regulates secretory and inflammatory processes and preterm birth is associated with inflammation. Therefore, our hypothesis was that anti-secretory factor might play a role in immune reactivity and homeostasis during pregnancy. Material and methods. Following spontaneous onset of labor and preterm or term delivery, placenta biopsies were collected. The levels of anti-secretory factor and markers of inflammation (CD68, CD163) and vascularization (CD34, smooth muscle actin) were analyzed by immunohistochemistry. Results. The 61 placental biopsies included 31 preterm (<37 weeks of gestation) and 30 term (37-41 weeks) samples. The preterm placentas exhibited lower levels of antisecretory factor (p = 0.008) and larger numbers of CD68-positive cells (p < 0.001) compared to term. Preterm placentas had blood vessel of smaller diameter (p = 0.036) indicative of immaturity. The level of interleukin-6 in cord blood was higher after very preterm than term birth, suggesting a fetal inflammatory response. The placenta level of anti-secretory factor was positively correlated to the length of gestation (p = 0.025) and negatively correlated to the levels of the inflammatory markers CD68 (p = 0.015) and CD163 (p = 0.028). Conclusions. Preterm delivery is associated with low levels of anti-secretory factor in placenta. Inflammation, a potential trigger of preterm birth, is more pronounced in the preterm placenta and inversely related to the placental level of anti-secretory factor, suggesting both a link and a potential target for intervention.
Introduction
Globally, more than one in 10 births are preterm, and preterm birth (PTB) is the most common cause of neonatal death (1) . The etiology is multifactorial and preventive treatment often ineffective (2) . In addition, PTB elevates the risk for morbidity during the perinatal period and can lead to lifelong disability with high societal costs (3) . PTB can be spontaneous or initiated for medical reasons (4) . It is unknown what triggers half of the spontaneous cases and a better understanding of the underlying pathophysiology would be of considerable value (5, 6) . Of interest in this context is the observation that preterm premature rupture of membranes (PPROM) occurs in 1-2% of pregnancies and is associated with elevated maternal and neonatal morbidity (7) . Moreover, cervical ripening is an inflammatory reaction that is required for a vaginal PTB to occur (8) . There are no signs of infection normally associated with cervical ripening, but there is an influx of inflammatory cells including dendritic cells (9) .
Anti-secretory factor (AF), an endogenous protein with potent anti-inflammatory effects, regulates the transport of water and ions across cell membranes via nerves as well as receptors, binding proteins and transport channels. AF is present in most human tissues and body fluids, including placental tissue (10) , and its expression by macrophages and dendritic cells indicates immune-regulatory properties (11) . Normally present in an inactive form, AF becomes activated as part of the innate immune response, for example following exposure to bacterial toxins (10) . The controlled inflammation associated with normal pregnancy may be more severe and/or uncontrolled in the case of PTB (12) . Here, we tested the hypothesis that AF may play a role in immune reactivity and homeostasis during pregnancy by examining the level of AF in placental tissue in relation to the degree of inflammation and length of gestation.
Material and methods
After obtaining written informed consent, women admitted for delivery at Karolinska University Hospital, Stockholm, Sweden, were included prospectively in a larger longitudinal project on PTB. Women ≥18 years of age with spontaneous onset of delivery were asked to participate. The exclusion criteria were multiple pregnancy, use of tobacco, presence of preeclampsia, diabetes, other systemic disease (such as multiple sclerosis or systemic lupus erythematosus) and known fetal malformations. Birth before the 37th week of gestation was defined as preterm. When labor began at <34 weeks of gestation, the clinical routine was to administrate antenatal steroids to enhance fetal lung maturation. The participants were categorized retrospectively into three groups based on length of gestation: (i) very preterm birth (VPT) categorized as <32 weeks of gestation, (ii) moderately preterm birth (MPT) 32-36 completed weeks or (iii) term birth (TB) 37-41 weeks.
Obstetrical data were collected prospectively from the medical records of the participants. At birth, a biopsy (1 91 cm) was taken through full thickness from the central part of the placenta, rinsed in physiological saline solution and then immediately fixed in 4% aqueous formaldehyde for a maximum of 24 h, followed by dehydration in 70% ethanol solution and, finally, embedding in paraffin for morphological immunohistochemical analyses. Sections 4 lm thick of the paraffinembedded samples were mounted on to Menzel-gl€ azer Superfrost â Plus glass slides (Menzel GmbH&Co KG, Braunschwieg, Germany). The sections to be utilized for immunohistochemistry were deparaffinized, hydrated and treated with a solution of 3% hydrogen peroxide to stop endogenous peroxidase activity. Heat-induced retrieval of antigen was achieved in an ethylenediaminetetraacetic acid (EDTA) buffer, pH 8.0 (for monoclonal antibodies) or in a citrate buffer, pH 6 (for polyclonal antibodies). Two different antibodies were used for AF visualization: MK43, a mouse monoclonal IgM antibody, was used to detect the active form of AF, and P8, a polyclonal affinity purified rabbit antiserum, to detect the total amount of AF, both active and inactive forms. To determine the level of inflammation, additional sections were incubated with monoclonal mouse antibodies against CD68 (clone PG-M1; Dako, Glostrup, Denmark) or CD163 (antibodies-on-line GmbH, Aachen, Germany). Placental vascularity changes with gestational age and vascularization was assessed by incubating sections with monoclonal antibodies against CD34 (Novocastra, Triolab, Molndal, Sweden) and smooth muscle actin (SMA) (Sigma-Aldrich, St Louis, MO, USA), which recognize myofibroblasts in the smooth muscle of blood vessel walls. Secondary incubations were performed with peroxidase-conjugated goat anti-mouse IgM (Jackson Immune Research Lab Inc., Ely, Cambridgeshire, UK) for MK43, anti-mouse Impress-HRP reagent (Vector Laboratories, Burlingame, CA, USA) for the other mouse monoclonal antibodies, and anti-rabbit Impress-HRP reagent (Vector Laboratories) for P8. Immunoreactivity was visualized in brown employing the Liquid DAB+ substrate chromogen system (Dako). Cell nuclei were counterstained with hematoxylin. Four batches of tissue samples were stained, each batch including placental tissue from all gestational ages.
A blinded semiquantitative evaluation of the staining of the fetal part of the placenta was performed independently by two investigators, with an inter-rater reliability of approximately 90%. When there was no consensus, the mean value was used. With 10-fold magnification, at least
Key Message
Preterm placenta contains lower levels of active antisecretory factor and more markers of inflammation compared with term placenta. More active antisecretory factor in placenta is linked to length of gestation close to term. Immune responses regulating preterm delivery may involve antisecretory factor. four different visual fields in the central portion of the chorion villi were analyzed. The intensity of the staining for AF was evaluated in the syncytiotrophoblast layer of the villi and for CD68, CD163 and SMA in the entire villi. This intensity was rated on an ordinal seven-step scale (Table 1) . Using CD34 as a marker, the number of blood vessels in each villus with a diameter between 50 and 100 lm was counted. A minimum of 35 villi in four different visual fields were analyzed at 200-fold magnification and the mean number of vessels/villus calculated. In addition, the mean diameter of the vessels was categorized as small, small to intermediate, intermediate, intermediate to large or large. The presence of funisitis in the placenta was assessed on the basis of the level of interleukin-6 (IL-6) in cord blood, with >11 pg/mL being considered positive (13) . IL-6 was quantified with the Bio-Plex human cytokine assay (Bio-Rad Laboratories Inc., Hercules, CA, USA), at the Research Laboratory for Reproductive Health, Karolinska Institutet.
Statistical analyses
All calculations were performed with the SPSS software STATISTICS 22 (SPSS Inc., Chicago, IL, USA). Data exhibiting a normal distribution are expressed as means AE standard deviations and other data as medians and ranges. Differences between groups with respect to background factors were examined using the Chi-square test, ANOVA and Kruskal-Wallis test and with respect to placental levels of AF, MK 43 and P8, and inflammatory markers with the Kruskal-Wallis or Mann-Whitney Utest. Potential correlations between length of gestation and AF, inflammatory markers and vascularization were examined using Spearman's rank correlation test. A pvalue <0.05 was considered to be statistically significant.
Ethical approval
The study was approved by the regional Ethical Review Board in Stockholm, Sweden (Dnr 04-637/4).
Results
Of the 61 women included, 11 gave birth VPT, 20 MPT and 30 normal TB. All women in the VPT group received antenatal steroid treatment. The maternal and infant characteristics are reported in Table 2 . There was no correlation between infant sex and the level of AF (p = 0.303). There were no differences in the levels of AF, inflammatory markers or vascularization in relation to mode of delivery. The exception was the higher placental staining for CD163 following vaginal delivery than cesarean section in the VPT group (median 7.4 vs. 3.5, p = 0.039). More placentas in the VPT group exhibited funisitis defined as >11 pg/mL IL-6 in cord blood (Table 2, Figure 1 ). The placental levels of AF were independent of the level of IL-6 in cord blood.
Anti-secretory factor was present in the outer syncytiotrophoblast layer of the villi of all the placenta biopsies ( Figure 2 ). Shorter gestation was associated with a lower level of the active form of AF (Spearman's rho = 0.286, p = 0.025) (Figure 3a) . Thus, the number of AF-MK43-positive cells staining with high intensity was higher in term than in preterm placentas. The total level of AF, both the active and inactive forms as reflected in the number of AF-P8-positive cells, was inversely correlated to the length of gestation (Spearman's rho = À0.249, p = 0.053), with a higher level in the VPT than the TB group (p = 0.046, Figure 3b) .
The degree of inflammation in placental tissue was influenced by the length of gestation, with a higher number of CD68-positive cells in preterm than in term placentas (Spearman's rho = À0.576, p < 0.001) (Figure 3c) . Similarly, the numbers of CD163-positive cells were higher in the MPT and VPT groups than the TB group (p < 0.001), but there was no difference between the MPT and VPT groups themselves (Spearman's rho = À0.504, p < 0.001) (Figure 3d ).
Vascularization as reflected by the number of blood vessels per villus was independent of the length of gestation (Figure 3e) . However, the diameter of these blood vessels was smaller in the VPT than in the other two groups (p < 0.001), but no difference between the MPT and TB groups (Spearman's rho = 0.429, p = 0.001) (Figure 3f) . There was also a positive correlation between the diameter of the blood vessels and the birthweight of the infant (Spearman's rho = 0.328, p = 0.010). SMA was more abundant in the VPT than in the MPT and TB groups (p = 0.010, data not shown).
The levels of AF-MK43 were negatively correlated to that of both CD68 (Spearman's rho = À0.310, p = 0.015) and CD163 (Spearman's rho = À0.282, p = 0.028). There was no difference between the levels of AF-MK43 levels with more or less than >11 pg/mL IL-6 in cord blood, irrespective of the length of gestation. Finally, the level of AF-MK43 was positively correlated to the diameter of villus blood vessels (Spearman's rho = 0.368, p = 0.004).
Discussion
This is the first demonstration that the level of active AF in the placenta is lower when the length of gestation is shorter, the level of inflammatory markers is higher, and the placental vascular architecture less well developed. These findings indicate that AF may be involved in regulating inflammatory processes in the placenta during pregnancy, although the possibility that the level of this factor increases normally during gestation cannot be excluded. Among the women with spontaneous onset of delivery identified, those with preeclampsia and systemic inflammatory disease were excluded to minimize the risk of confounding by factors such as vascular compromise and inflammation. Since the role of AF in vascular development is unknown, the number of capillaries/villus was counted to exclude the possibility that our findings simply reflected defective vascularization. Whether the levels of AF are correlated to vascularization or only to gestational age remains to be determined. Furthermore, the relatively small sample size precludes definitive . Levels of interleukin 6 (IL-6) in umbilical cord blood in relation to length of gestation. These levels (10-90 percentiles) following term birth (TB; defined as occurring after 37-41 weeks of gestation), moderately preterm birth (MPT; after 32-36 weeks) and very preterm birth (VPT; after <32 weeks of gestation) were logtransformed prior to analyses to account for skewedness. The mean and median levels of IL-6 (pg/mL) were 11.0 and 4.9 for the TB group; 8.3 and 1.7 for the MPT group; 298.2 and 44.9 for the VPT group. Analysis by ANOVA with Bonferroni correction revealed significant differences between VPT and both the other groups (**p < 0.01).
conclusions. The number of cells staining positive for AF-MK43 in placenta tissue was positively correlated to length of gestation. At the same time, there was an inverse relation between staining for AF-MK-43 and AF-P8. The polyclonal P8 antibodies bind primarily to a variety of amino acid sequences in the P8 peptide and may cross-react with other unrelated peptides as well, whereas the anti-AF-MK43 antibodies recognize only a single sequence of three to five amino acids in the peptide chain, reducing the risk for cross-reactivity (14) . Accompaniment of the increasing maturity of the placenta by a reduction in P8 staining and elevation of the MK43 signal indicates that AF becomes more active during this process. A high placental level of AF has already been demonstrated (14) but this level has not previously been related to the length of gestation. We propose that activation of AF proceeds during gestation due to a conformational change, but this remains to be demonstrated.
Immune tolerance is important for a successful pregnancy (15) . Allograft rejection initiated by cells and/or antibodies during pregnancy can present as chorioamnionitis or villitis of unknown etiology. Complement activation has been suggested to underlie antibody-mediated allograft rejection and HLA resistance during the mid-trimester, which might elevate the risk factors for spontaneous PTB (16) . Active AF converts complement factor 3 (C3) into its inactive form (17, 18) and induces the activity of proteasomes, thereby controlling inflammation (17) . We detected large numbers of CD68-positive cells in the preterm placenta, which might be directly related to inflammatory processes. Previous investigations have demonstrated elevated numbers of CD68-positive placental cells following miscarriage (19) and recurrent loss of pregnancy (20) . Moreover, the incidence of acute chorioamnionitis falls gradually as the length of gestation increases (21) . Both increased and decreased numbers of CD68-positive cells in placentas exhibiting chorioamnionitis have been reported (22, 23) . Together, these results suggest that CD68-positive cells play a role in regulating placental infections and inflammation. Since we lack detailed information about the chorioamnionitis, it is not possible to distinguish here between acute or chronic inflammation. However, to detect occurrence of the fetal inflammatory syndrome (FIRS) and signs of funisitis, we employed >11 pg/mL of IL-6 in cord blood as a marker (13, 24) . The differences observed are indicative of FIRS and funisitis in the VPT group, which confirms previous reports of more extensive inflammation in this group (24) . FIRS has been associated with both fetal (25) and neonatal complications (23) , as well as enhanced perinatal morbidity and mortality (26) . Our preterm placentas also displayed high levels of CD163, which is in agreement with the findings of Ben Amara et al. (22) . Interestingly, those investigators also reported more pronounced expression of CD163 in connection with higher-grade chorioamnionitis. During early pregnancy, decidual macrophages involved in immunomodulation and tissue remodeling express CD163 (27, 28) . However, this surface antigen has also been associated with production of the pro-inflammatory cytokine IL-12, suggesting that there is a plasticity and interaction between these two molecules during complications of pregnancy (29) . A change in the characteristics of macrophages from anti-inflammatory to pro-inflammatory has Immunohistochemistry and light microscopy were used to stain and visualize the cells, respectively, the diameters of blood vessels designated as 1 (small) to 5 (large) (**p < 0.01 and ***p < 0.001).
been suggested to elevate the risk of preterm labor (12) . Our findings of higher levels of CD163 in the VPT and MPT groups may be related to regulation of inflammation designed to maintain pregnancy, and/or to such a change in phenotype. In vitro, glucocorticosteroids upregulate the expression of CD163 expression (30) , whereas, in animals, stress and high plasma levels of corticoids are correlated to low levels of AF (10) . Consequently, corticosteroid treatment might stimulate CD163 levels while simultaneously suppressing the levels of AF. Antenatal corticosteroids were administrated to all of the women in the VPT birth group but only one in the MPT birth group. This latter group involved three cases of PTB at 33 weeks of gestation where no antenatal steroids were given, despite clinical guidelines. The level of CD163 was higher in both the VPT and MPT groups than in the TB group, indicating an association between the length of gestation and level of CD163, irrespective of corticosteroid treatment. In summary, our findings of higher levels of inflammatory markers with shorter gestation are consistent with published data and indicate that more pronounced inflammation could be expected in the preterm placenta tissue. Inadequate maternal and/or fetal vascularization and inflammation of placental tissue are pathophysiological aspects of extremely preterm deliveries (6) . Here, we found blood vessels of smaller diameter in combination with higher levels of SMA in the VPT birth than in either the MPT birth or TB groups. The lack of any differences in the numbers of blood vessels in the placental villi may reflect normal vascularization in all cases. However, a higher level of AF-MK43 was positively correlated to a larger diameter of blood vessels, suggesting that this protein plays a role in the maturation of and homeostasis in the placenta during pregnancy. We conclude that with preterm delivery, placental levels of active AF are lower than with term delivery. A high level of active AF in the placenta is linked not only to the length of gestation but also to a more mature vascular structure, whereas lower levels appear to be associated with enhanced inflammation. Accordingly, AF may possibly regulate inflammation in the placenta in a manner so as to prolong gestation. Moreover, this factor may be involved in the complex pathophysiology of prematurity, a novel finding that warrants further research. 
